Effect	0	6	O
of	7	9	O
transplanted	10	22	O
mesenchymal	23	34	B-Cell
stem	35	39	I-Cell
cells	40	45	I-Cell
from	46	50	O
rats	51	55	B-Organism
of	56	58	O
different	59	68	O
ages	69	73	O
on	74	76	O
the	77	80	O
improvement	81	92	O
of	93	95	O
heart	96	101	B-Organ
function	102	110	O
after	111	116	O
acute	117	122	O
myocardial	123	133	O
infarction	134	144	O
.	144	145	O

BACKGROUND	147	157	O
:	157	158	O
Mesenchymal	159	170	B-Cell
stem	171	175	I-Cell
cells	176	181	I-Cell
(	182	183	O
MSCs	183	187	B-Cell
)	187	188	O
transplantation	189	204	O
is	205	207	O
of	208	210	O
therapeutic	211	222	O
potential	223	232	O
after	233	238	O
ischemic	239	247	O
injury	248	254	O
in	255	257	O
both	258	262	O
experimental	263	275	O
and	276	279	O
clinical	280	288	O
studies	289	296	O
.	296	297	O

Clinically	298	308	O
,	308	309	O
elderly	310	317	O
patients	318	326	B-Organism
are	327	330	O
more	331	335	O
vulnerable	336	346	O
to	347	349	O
acute	350	355	O
myocardial	356	366	O
infarction	367	377	O
(	378	379	O
AMI	379	382	O
)	382	383	O
.	383	384	O

But	385	388	O
little	389	395	O
is	396	398	O
known	399	404	O
about	405	410	O
the	411	414	O
characteristics	415	430	O
of	431	433	O
young	434	439	O
donor	440	445	O
-	445	446	O
derived	446	453	O
MSCs	454	458	B-Cell
transplanted	459	471	O
to	472	474	O
old	475	478	O
patients	479	487	B-Organism
with	488	492	O
AMI	493	496	O
.	496	497	O

The	498	501	O
present	502	509	O
study	510	515	O
was	516	519	O
designed	520	528	O
to	529	531	O
investigate	532	543	O
the	544	547	O
effect	548	554	O
of	555	557	O
transplanted	558	570	O
MSCs	571	575	B-Cell
from	576	580	O
rats	581	585	B-Organism
of	586	588	O
different	589	598	O
ages	599	603	O
on	604	606	O
the	607	610	O
improvement	611	622	O
of	623	625	O
heart	626	631	B-Organ
function	632	640	O
after	641	646	O
AMI	647	650	O
.	650	651	O

METHODS	652	659	O
:	659	660	O
MSCs	661	665	B-Cell
from	666	670	O
Sprague	671	678	B-Organism
-	678	679	I-Organism
Dawley	679	685	I-Organism
(	686	687	I-Organism
SD	687	689	I-Organism
)	689	690	I-Organism
rats	691	695	I-Organism
were	696	700	O
isolated	701	709	O
and	710	713	O
cultured	714	722	O
in	723	725	O
vitro	726	731	O
.	731	732	O

The	733	736	O
apoptosis	737	746	O
characteristics	747	762	O
of	763	765	O
MSCs	766	770	B-Cell
were	771	775	O
observed	776	784	O
under	785	790	O
conditions	791	801	O
of	802	804	O
ischemia	805	813	O
and	814	817	O
anoxia	818	824	O
.	824	825	O

SD	826	828	B-Organism
rats	829	833	I-Organism
underwent	834	843	O
MI	844	846	O
received	847	855	O
intramyocardial	856	871	O
injection	872	881	O
of	882	884	O
MSCs	885	889	B-Cell
from	890	894	O
young	895	900	O
donor	901	906	O
rats	907	911	B-Organism
(	912	913	O
n	913	914	O
=	915	916	O
8	917	918	O
)	918	919	O
,	919	920	O
old	921	924	O
donor	925	930	O
rats	931	935	B-Organism
(	936	937	O
n	937	938	O
=	939	940	O
8	941	942	O
)	942	943	O
,	943	944	O
respectively	945	957	O
.	957	958	O

AMI	959	962	O
control	963	970	O
group	971	976	O
received	977	985	O
equal	986	991	O
volume	992	998	O
physiological	999	1012	O
saline	1013	1019	O
.	1019	1020	O

Immunofluorescence	1021	1039	O
was	1040	1043	O
used	1044	1048	O
to	1049	1051	O
observe	1052	1059	O
the	1060	1063	O
differentiation	1064	1079	O
of	1080	1082	O
the	1083	1086	O
grafted	1087	1094	O
cells	1095	1100	B-Cell
into	1101	1105	O
cardiomyocytes	1106	1120	B-Cell
.	1120	1121	O

Four	1122	1126	O
weeks	1127	1132	O
after	1133	1138	O
cell	1139	1143	B-Cell
transplantation	1144	1159	O
,	1159	1160	O
reverse	1161	1168	O
transcriptase	1169	1182	O
-	1182	1183	O
polymerase	1183	1193	O
chain	1194	1199	O
reaction	1200	1208	O
(	1209	1210	O
RT	1210	1212	O
-	1212	1213	O
PCR	1213	1216	O
)	1216	1217	O
and	1218	1221	O
immunohistochemistry	1222	1242	O
for	1243	1246	O
vascular	1247	1255	B-Gene_or_gene_product
endothelial	1256	1267	I-Gene_or_gene_product
growth	1268	1274	I-Gene_or_gene_product
factor	1275	1281	I-Gene_or_gene_product
(	1282	1283	O
VEGF	1283	1287	B-Gene_or_gene_product
)	1287	1288	O
,	1288	1289	O
VIII	1290	1294	B-Gene_or_gene_product
-	1294	1295	I-Gene_or_gene_product
factor	1295	1301	I-Gene_or_gene_product
immunohistochemistry	1302	1322	O
for	1323	1326	O
vessel	1327	1333	B-Multi-tissue_structure
density	1334	1341	O
,	1341	1342	O
TUNEL	1343	1348	O
,	1348	1349	O
caspase	1350	1357	B-Gene_or_gene_product
-	1357	1358	I-Gene_or_gene_product
3	1358	1359	I-Gene_or_gene_product
for	1360	1363	O
cardiomyocyte	1364	1377	B-Cell
apoptosis	1378	1387	O
,	1387	1388	O
echocardiography	1389	1405	O
and	1406	1409	O
hemodynamic	1410	1421	O
detection	1422	1431	O
for	1432	1435	O
heart	1436	1441	B-Organ
function	1442	1450	O
were	1451	1455	O
performed	1456	1465	O
.	1465	1466	O

RESULTS	1467	1474	O
:	1474	1475	O
The	1476	1479	O
apoptosis	1480	1489	O
rate	1490	1494	O
of	1495	1497	O
the	1498	1501	O
old	1502	1505	O
donor	1506	1511	O
-	1511	1512	O
derived	1512	1519	O
MSCs	1520	1524	B-Cell
group	1525	1530	O
was	1531	1534	O
significantly	1535	1548	O
higher	1549	1555	O
than	1556	1560	O
that	1561	1565	O
of	1566	1568	O
the	1569	1572	O
young	1573	1578	O
donor	1579	1584	O
-	1584	1585	O
derived	1585	1592	O
MSCs	1593	1597	B-Cell
group	1598	1603	O
under	1604	1609	O
conditions	1610	1620	O
of	1621	1623	O
ischemia	1624	1632	O
and	1633	1636	O
anoxia	1637	1643	O
(	1644	1645	O
P	1645	1646	O
less	1648	1652	O
than	1653	1657	O
0	1659	1660	O
.	1660	1661	O
05	1661	1663	O
)	1663	1664	O
.	1664	1665	O

Engrafted	1666	1675	O
MSCs	1676	1680	B-Cell
survived	1681	1689	O
,	1689	1690	O
proliferated	1691	1703	O
and	1704	1707	O
differentiated	1708	1722	O
into	1723	1727	O
myocardium	1728	1738	B-Cell
-	1738	1739	I-Cell
like	1739	1743	I-Cell
cells	1744	1749	I-Cell
.	1749	1750	O

VEGF	1751	1755	B-Gene_or_gene_product
gene	1756	1760	O
expression	1761	1771	O
and	1772	1775	O
capillary	1776	1785	B-Tissue
density	1786	1793	O
in	1794	1796	O
the	1797	1800	O
old	1801	1804	O
donor	1805	1810	O
-	1810	1811	O
derived	1811	1818	O
group	1819	1824	O
were	1825	1829	O
lower	1830	1835	O
than	1836	1840	O
those	1841	1846	O
in	1847	1849	O
the	1850	1853	O
young	1854	1859	O
donor	1860	1865	O
-	1865	1866	O
derived	1866	1873	O
group	1874	1879	O
but	1880	1883	O
higher	1884	1890	O
than	1891	1895	O
those	1896	1901	O
in	1902	1904	O
the	1905	1908	O
control	1909	1916	O
group	1917	1922	O
(	1923	1924	O
P	1924	1925	O
less	1927	1931	O
than	1932	1936	O
0	1938	1939	O
.	1939	1940	O
05	1940	1942	O
)	1942	1943	O
.	1943	1944	O

The	1945	1948	O
transplantation	1949	1964	O
of	1965	1967	O
old	1968	1971	O
donor	1972	1977	O
-	1977	1978	O
derived	1978	1985	O
MSCs	1986	1990	B-Cell
attenuated	1991	2001	O
apoptosis	2002	2011	O
of	2012	2014	O
cardiomyocytes	2015	2029	B-Cell
in	2030	2032	O
the	2033	2036	O
peri	2037	2041	O
-	2041	2042	O
infarct	2042	2049	O
region	2050	2056	O
compared	2057	2065	O
with	2066	2070	O
the	2071	2074	O
control	2075	2082	O
group	2083	2088	O
and	2089	2092	O
the	2093	2096	O
effect	2097	2103	O
was	2104	2107	O
elevated	2108	2116	O
in	2117	2119	O
young	2120	2125	O
donor	2126	2131	O
-	2131	2132	O
derived	2132	2139	O
MSCs	2140	2144	B-Cell
(	2145	2146	O
P	2146	2147	O
less	2149	2153	O
than	2154	2158	O
0	2160	2161	O
.	2161	2162	O
05	2162	2164	O
)	2164	2165	O
.	2165	2166	O

The	2167	2170	O
heart	2171	2176	B-Organ
functions	2177	2186	O
(	2187	2188	O
left	2188	2192	O
ventricle	2193	2202	B-Multi-tissue_structure
ejection	2203	2211	O
fraction	2212	2220	O
(	2221	2222	O
LVEF	2222	2226	O
)	2226	2227	O
,	2227	2228	O
left	2229	2233	O
ventricle	2234	2243	B-Multi-tissue_structure
fractional	2244	2254	O
shortening	2255	2265	O
(	2266	2267	O
LVFS	2267	2271	O
)	2271	2272	O
)	2272	2273	O
were	2274	2278	O
improved	2279	2287	O
more	2288	2292	O
significantly	2293	2306	O
in	2307	2309	O
the	2310	2313	O
old	2314	2317	O
donor	2318	2323	O
-	2323	2324	O
derived	2324	2331	O
MSCs	2332	2336	B-Cell
group	2337	2342	O
than	2343	2347	O
in	2348	2350	O
the	2351	2354	O
control	2355	2362	O
group	2363	2368	O
and	2369	2372	O
the	2373	2376	O
heart	2377	2382	B-Organ
function	2383	2391	O
in	2392	2394	O
the	2395	2398	O
young	2399	2404	O
donor	2405	2410	O
-	2410	2411	O
derived	2411	2418	O
MSCs	2419	2423	B-Cell
group	2424	2429	O
further	2430	2437	O
improved	2438	2446	O
(	2447	2448	O
P	2448	2449	O
less	2451	2455	O
than	2456	2460	O
0	2462	2463	O
.	2463	2464	O
05	2464	2466	O
)	2466	2467	O
.	2467	2468	O

CONCLUSIONS	2469	2480	O
:	2480	2481	O
Young	2482	2487	O
donor	2488	2493	O
-	2493	2494	O
derived	2494	2501	O
MSCs	2502	2506	B-Cell
can	2507	2510	O
improve	2511	2518	O
heart	2519	2524	B-Organ
function	2525	2533	O
significantly	2534	2547	O
through	2548	2555	O
angiogenesis	2556	2568	O
and	2569	2572	O
decreasing	2573	2583	O
cardiomyocyte	2584	2597	B-Cell
apoptosis	2598	2607	O
when	2608	2612	O
transplanted	2613	2625	O
to	2626	2628	O
the	2629	2632	O
infarcted	2633	2642	O
area	2643	2647	O
.	2647	2648	O

